Manulife (Manufacturers Life Insurance)’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.2M Buy
112,727
+201
+0.2% +$25.3K 0.01% 707
2025
Q1
$12.4M Buy
112,526
+2,217
+2% +$245K 0.01% 749
2024
Q4
$15.1M Sell
110,309
-6,943
-6% -$948K 0.01% 714
2024
Q3
$13.5M Sell
117,252
-8,149
-6% -$939K 0.01% 758
2024
Q2
$17.3M Buy
125,401
+1,074
+0.9% +$148K 0.02% 652
2024
Q1
$17.1M Buy
124,327
+7,372
+6% +$1.02M 0.02% 669
2023
Q4
$15.4M Buy
116,955
+18,070
+18% +$2.38M 0.01% 697
2023
Q3
$11.1M Buy
98,885
+4,345
+5% +$489K 0.01% 764
2023
Q2
$8.92M Sell
94,540
-3,724
-4% -$351K 0.01% 838
2023
Q1
$9.95M Sell
98,264
-2,853
-3% -$289K 0.01% 801
2022
Q4
$12.1M Sell
101,117
-1,290
-1% -$154K 0.01% 733
2022
Q3
$10.8M Buy
102,407
+728
+0.7% +$76.7K 0.01% 764
2022
Q2
$9.93M Buy
101,679
+1,768
+2% +$173K 0.01% 827
2022
Q1
$9.34M Sell
99,911
-7,233
-7% -$676K 0.01% 930
2021
Q4
$9.12K Sell
107,144
-1,843
-2% -$157 0.01% 984
2021
Q3
$10.5M Buy
108,987
+5,465
+5% +$524K 0.01% 910
2021
Q2
$10.1M Sell
103,522
-7,037
-6% -$685K 0.01% 961
2021
Q1
$10.8M Buy
+110,559
New +$10.8M 0.01% 916
2020
Q3
Sell
-1,931
Closed -$242K 2927
2020
Q2
$242K Buy
+1,931
New +$242K ﹤0.01% 2395
2020
Q1
Sell
-2,290
Closed -$246K 2872
2019
Q4
$246K Sell
2,290
-85
-4% -$9.13K ﹤0.01% 2458
2019
Q3
$214K Sell
2,375
-114
-5% -$10.3K ﹤0.01% 2540
2019
Q2
$210K Buy
+2,489
New +$210K ﹤0.01% 2615
2018
Q4
Sell
-2,209
Closed -$272K 2716
2018
Q3
$272K Sell
2,209
-302
-12% -$37.2K ﹤0.01% 2584
2018
Q2
$247K Sell
2,511
-13
-0.5% -$1.28K ﹤0.01% 2951
2018
Q1
$209K Sell
2,524
-117
-4% -$9.69K ﹤0.01% 2988
2017
Q4
$205K Sell
2,641
-75
-3% -$5.82K ﹤0.01% 2979
2017
Q3
$167K Buy
2,716
+51
+2% +$3.14K ﹤0.01% 3118
2017
Q2
$123K Buy
2,665
+193
+8% +$8.91K ﹤0.01% 3299
2017
Q1
$107K Sell
2,472
-18
-0.7% -$779 ﹤0.01% 3159
2016
Q4
$97K Sell
2,490
-20
-0.8% -$779 ﹤0.01% 3236
2016
Q3
$127K Buy
2,510
+141
+6% +$7.13K ﹤0.01% 3087
2016
Q2
$108K Sell
2,369
-123,361
-98% -$5.62M ﹤0.01% 3184
2016
Q1
$4.67M Buy
125,730
+810
+0.6% +$30.1K ﹤0.01% 1072
2015
Q4
$7.07K Sell
124,920
-7,207
-5% -$408 0.01% 848
2015
Q3
$5.26K Buy
132,127
+78,541
+147% +$3.13K 0.01% 988
2015
Q2
$2.56K Buy
53,586
+759
+1% +$36 ﹤0.01% 1345
2015
Q1
$2.1K Buy
52,827
+4,863
+10% +$193 ﹤0.01% 1385
2014
Q4
$1.07K Sell
47,964
-1,119
-2% -$25 ﹤0.01% 1544
2014
Q3
$770 Buy
49,083
+1,041
+2% +$16 ﹤0.01% 1726
2014
Q2
$712K Sell
48,042
-2,185
-4% -$32.4K ﹤0.01% 1803
2014
Q1
$808 Sell
50,227
-438
-0.9% -$7 ﹤0.01% 1773
2013
Q4
$473 Sell
50,665
-1,104
-2% -$10 ﹤0.01% 2094
2013
Q3
$586 Sell
51,769
-1,574
-3% -$18 ﹤0.01% 1894
2013
Q2
$714K Buy
+53,343
New +$714K ﹤0.01% 1656